Issued Patents All Time
Showing 1–23 of 23 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12214022 | Sequence-specific antimicrobials by blocking DNA repair | David Bikard, Lun Cui, Jesus Fernandez Rodriguez | 2025-02-04 |
| 12214070 | Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysins | Antoine Decrulle | 2025-02-04 |
| 12098372 | Microbiome modulation of a host by delivery of DNA payloads with minimized spread | Jesus Fernandez Rodriguez | 2024-09-24 |
| 11970716 | Transcriptional control in prokaryotic cells using DNA-binding repressors | Jesus Fernandez Rodriguez, Antonina Krawczyk | 2024-04-30 |
| 11952594 | Pharmaceutical compositions comprising bacterial delivery vehicles and uses thereof | Antoine Decrulle, Igor STZEPOURGINSKI | 2024-04-09 |
| 11946056 | Optimized vector for delivery in microbial populations | Antoine Decrulle, Jesus Fernandez Rodriguez, David Bikard | 2024-04-02 |
| 11905516 | Optimized vector for delivery in microbial populations | Antoine Decrulle, Jesus Fernandez Rodriguez, David Bikard | 2024-02-20 |
| 11839645 | Therapeutic use of engineered postbiotics comprising bacteriocins and/or endolysins | Antoine Decrulle | 2023-12-12 |
| 11746352 | Microbiome modulation of a host by delivery of DNA payloads with minimized spread | Jesus Fernandez Rodriguez | 2023-09-05 |
| 11690880 | Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders | Antoine Decrulle, Cristina del Carmen Gil-Cruz, Christian Ivan Pérez-Shibayama, Burkhard Ludewig, Jesus Fernandez Rodriguez +1 more | 2023-07-04 |
| 11633348 | Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysins | Antoine Decrulle | 2023-04-25 |
| 11617773 | Elimination of colonic bacterial driving lethal inflammatory cardiomyopathy | Cristina del Carmen Gil-Cruz, Christian Ivan Pérez-Shibayama, Burkhard Ludewig | 2023-04-04 |
| 11584781 | Chimeric receptor binding proteins resistant to proteolytic degradation | Jesus Fernandez Rodriguez | 2023-02-21 |
| 11584918 | Transcriptional control in prokaryotic cells using DNA-binding repressors | Jesus Fernandez Rodriguez, Antonina Krawczyk | 2023-02-21 |
| 11541106 | Method for killing bacteria with an engineered postbiotic | Antoine Decrulle | 2023-01-03 |
| 11534467 | Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders | Antoine Decrulle, Cristina del Carmen Gil-Cruz, Christian Ivan Pérez-Shibayama, Burkhard Ludewig, Jesus Fernandez Rodriguez +1 more | 2022-12-27 |
| 11376286 | Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders | Antoine Decrulle, Cristina del Carmen Gil-Cruz, Christian Ivan Pérez-Shibayama, Burkhard Ludewig, Jesus Fernandez Rodriguez +1 more | 2022-07-05 |
| 11357831 | Sequence-specific antimicrobials by blocking DNA repair | David Bikard, Lun Cui, Jesus Fernandez Rodriguez | 2022-06-14 |
| 11224621 | Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders | Antoine Decrulle, Cristina del Carmen Gil-Cruz, Christian Ivan Pérez-Shibayama, Burkhard Ludewig, Jesus Fernandez Rodriguez +1 more | 2022-01-18 |
| 11124776 | Pharmaceutical compositions comprising bacterial delivery vehicles and uses thereof | Antoine Decrulle, Igor STZEPOURGINSKI | 2021-09-21 |
| 11078490 | Optimized vector for delivery in microbial populations | Antoine Decrulle, Jesus Fernandez Rodriguez, David Bikard | 2021-08-03 |
| 10808254 | Optimized vector for delivery in microbial populations | Antoine Decrulle, Jesus Fernandez Rodriguez, David Bikard | 2020-10-20 |
| 10731153 | Recombinases and target sequences | Ron Weiss, Gregory Batt, Yinqing Li | 2020-08-04 |